Form 4: Grace Therapeutics Insider Buys Shares
Insider Transaction (Form 4)
Opaleye Management Inc. reported changes in beneficial ownership of Grace Therapeutics, Inc. common stock on October 1, 2026.
Summary
- Open-market purchase: acquired 38,796 Common Stock, par value $0.0001 per share at $2.04 ($78,962) on October 1, 2026; holds 2,836,963 after (Indirect).
- Open-market purchase: acquired 20,000 Common Stock, par value $0.0001 per share at $2.07 ($41,368) on October 2, 2026; holds 2,856,963 after (Indirect).
- Open-market purchase: acquired 1,694 Common Stock, par value $0.0001 per share at $2.06 ($3,490) on October 5, 2026; holds 2,858,657 after (Indirect).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $123,819, committing personal capital to the stock.
Insider Transactions
Opaleye Management Inc. — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Open-market purchase | Common Stock, par value $0.0001 per share | 38,796 | $2 | $79.0K | 2,836,963 |
| 2026-10-02 | Open-market purchase | Common Stock, par value $0.0001 per share | 20,000 | $2 | $41.4K | 2,856,963 |
| 2026-10-05 | Open-market purchase | Common Stock, par value $0.0001 per share | 1,694 | $2 | $3.5K | 2,858,657 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Open-market purchase (38,796 shares) |
| 2026-10-02 | Open-market purchase (20,000 shares) |
| 2026-10-05 | Open-market purchase (1,694 shares) |
Keywords
insider transaction, Form 4, GRCE, Grace Therapeutics, Inc., bullish, Opaleye Management Inc.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.